mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.091 |
0.09 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.09 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.09 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.09 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.09 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.09 |
mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.09 |
mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.1 |